There is a persistent gap between what Western pharmaceutical executives think they know about drug patent protection in Eurasia and […]

A Strategic Guide for Pharmaceutical IP Professionals, Formulation Scientists, and Generic Drug Developers Introduction: Why Patent Claims Decide Who Wins

Every pharmaceutical patent starts its life with a 20-year timer running from the filing date. By the time a new

Every patent portfolio in the pharmaceutical industry contains dead weight. Not metaphorically — literally. Compounds whose commercial logic evaporated years

Launching a drug without a freedom-to-operate analysis is like building a factory on land you haven’t verified you own. You

How to Win Biopharma Contracts by Entering the Deal Before Generic Entry Does Why Timing Is the Only Thing That

The Number Every Pharma Strategist Gets Wrong Ask a pharmaceutical executive how long a drug patent lasts in Asia-Pacific, and

How generic drug suppliers’ litigation histories expose supply chain risk, financial fragility, and competitive staying power — before you sign

A practical playbook for formulation vendors, CDMOs, and excipient suppliers on how to mine patent loss-of-exclusivity data to find, time,